Artiva Biotherapeutics Inc (ARTV) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Artiva Biotherapeutics Inc   (NASDAQ: ARTV)


Artiva Biotherapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Artiva Biotherapeutics Inc's ROI in the second quarter of 2026?
Artiva Biotherapeutics Inc recorded a cumulative net loss of $-91 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -51.55%.

Within the Healthcare sector 486 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3882, from total ROI ranking in the first quarter of 2026 at 4431.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -6.17 % -3.95 % 166.01 % 2396.65 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 354 95 118 138 162
Return On Investment (TTM) -51.55 % -67.89 % -56.19 % -46.82 % -40.02 %
ARTV's Overall Ranking # 3882 # 4431 # 3813 # 3764 # 3958
Seq. Investment Change TTM 37.37 % -14.07 % -11.75 % -9.93 % 40.61 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -91 -87 -84 -79 -75

ARTV Company Profile >> Back to ARTV Roi Comparisons >> See Annual ARTV Return On Investment



Return On Investment ARTV's Ranking
Within: No.
Industry # 73
Sector # 487
Overall # 3882

Return On Investment Statistics
High Average Low
-40.02 %
-61.81 %
-116.52 %
(Jun 30 2025)   (Dec 31 2024)







Financial Statements
Artiva Biotherapeutics Inc's II. Quarter Investments $ 354 Millions ARTV's Balance sheet
Artiva Biotherapeutics Inc's II. Quarter Income $ -25 Millions Quarterly ARTV's Income Statement
ARTV's Income by Division See ARTV's Income by Division


ARTV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024


Total Investments in Millions 118 197 0 0 0
Y / Y Investment Growth -40.28 % - - - -
Net Income in Millions -84 -65 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -71.16 % -33.13 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARTV's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARTV's Competitors
Subscribers only: Roi for Artiva Biotherapeutics Inc's Suppliers
Subscribers only: Return On Investment for ARTV's Customers

Other Ratios
ARTV's Roa ARTV's Inventory Turnover Ratio ARTV's Growth Rates ARTV's Dividend Statistics
ARTV's Profitability Ratios ARTV's Asset Turnover Ratio ARTV's Dividend Growth
ARTV's Roe ARTV's Valuation Ratios ARTV's Financial Strength Ratios ARTV's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T01:08:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.